Kaposiform Hemangioendothelioma (KHE) is a rare vascular tumour of the infancy and the first decade of life. It is locally aggressive and potentially life threatening when associated with consumptive coagulopathy, known as Kasabach-Merritt syndrome (KMS). No consensus or guideline for the therapy has been reached because of the lack of prospective trials, and the different standard care suggestions are based on retrospective case series.
Product ID:
106301
Handle IRIS:
11562/990438
Last Modified:
November 15, 2022
Bibliographic citation:
Chinello, Matteo; Di Carlo, Daniela; Olivieri, Francesca; Balter, Rita; De Bortoli, Massimiliano; Vitale, Virginia; Zaccaron, Ada; Bonetti, Elisa; Parisi, Alice; Cesaro, Simone,
Successful Management of Kaposiform Hemangioendothelioma with Long-Term Sirolimus Treatment: a Case Report and Review of the Literature«MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES»
, vol. 10
, n. 1
, 2018
, pp. 2018043-2018047